These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 9817477

  • 21. Nitric oxide production by coronary conductance and resistance vessels in hypercholesterolemia patients.
    Shiode N, Nakayama K, Morishima N, Yamagata T, Matsuura H, Kajiyama G.
    Am Heart J; 1996 Jun; 131(6):1051-7. PubMed ID: 8644581
    [Abstract] [Full Text] [Related]

  • 22. The role of nitric oxide in coronary vascular effects of estrogen in postmenopausal women.
    Guetta V, Quyyumi AA, Prasad A, Panza JA, Waclawiw M, Cannon RO.
    Circulation; 1997 Nov 04; 96(9):2795-801. PubMed ID: 9386140
    [Abstract] [Full Text] [Related]

  • 23. Basal release of endothelium-derived nitric oxide at site of spasm in patients with variant angina.
    Egashira K, Katsuda Y, Mohri M, Kuga T, Tagawa T, Shimokawa H, Takeshita A.
    J Am Coll Cardiol; 1996 May 04; 27(6):1444-9. PubMed ID: 8626956
    [Abstract] [Full Text] [Related]

  • 24. Platelet glycoprotein IIb/IIIa receptor blockade improves vascular nitric oxide bioavailability in patients with coronary artery disease.
    Heitzer T, Ollmann I, Köke K, Meinertz T, Munzel T.
    Circulation; 2003 Aug 05; 108(5):536-41. PubMed ID: 12874186
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Adrenomedullin causes coronary vasodilation in humans: effects of inhibition of nitric oxide synthesis.
    Ueda K, Teragawa H, Kimura M, Matsuda K, Higashi Y, Yamagata T, Oshima T, Yoshizumi M, Chayama K.
    J Cardiovasc Pharmacol; 2005 Oct 05; 46(4):534-9. PubMed ID: 16160609
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Insulin and insulin-like growth factor-I cause coronary vasorelaxation in vitro.
    Hasdai D, Rizza RA, Holmes DR, Richardson DM, Cohen P, Lerman A.
    Hypertension; 1998 Aug 05; 32(2):228-34. PubMed ID: 9719047
    [Abstract] [Full Text] [Related]

  • 31. Nitric oxide formation contributes to beta-adrenergic dilation of epicardial coronary arteries in response to intravenous administration of dobutamine in dogs.
    Yang H, Deng Y, Bi X, Chang Q, Bai J, Pan M, Xiang H, Liu H, Li X, Liu Y, Li C.
    J Huazhong Univ Sci Technolog Med Sci; 2004 Aug 05; 24(2):189-91. PubMed ID: 15315177
    [Abstract] [Full Text] [Related]

  • 32. The role of endogenous nitric oxide in the response of coronary blood flow to tachycardia.
    Heras M, Roig E, Pérez-Villa F, Paz M, Melis G, Rigol M, Epelde F, de Candia G, Sanz G.
    Coron Artery Dis; 1996 Feb 05; 7(2):149-54. PubMed ID: 8813447
    [Abstract] [Full Text] [Related]

  • 33. The role of nitric oxide in bradykinin-induced dilation of coronary resistance vessels in patients with hypercholesterolemia.
    Kato M, Shiode N, Teragawa H, Hirao H, Yamada T, Yamagata T, Matsuura H, Kajiyama G.
    Intern Med; 1999 May 05; 38(5):394-400. PubMed ID: 10397075
    [Abstract] [Full Text] [Related]

  • 34. Role of beta2 adrenergic receptors in human atherosclerotic coronary arteries.
    Barbato E, Piscione F, Bartunek J, Galasso G, Cirillo P, De Luca G, Iaccarino G, De Bruyne B, Chiariello M, Wijns W.
    Circulation; 2005 Jan 25; 111(3):288-94. PubMed ID: 15642763
    [Abstract] [Full Text] [Related]

  • 35. Postischemic vasodilation in human forearm is dependent on endothelium-derived nitric oxide.
    Meredith IT, Currie KE, Anderson TJ, Roddy MA, Ganz P, Creager MA.
    Am J Physiol; 1996 Apr 25; 270(4 Pt 2):H1435-40. PubMed ID: 8967386
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Coronary vascular nitric oxide activity in hypertension and hypercholesterolemia. Comparison of acetylcholine and substance P.
    Quyyumi AA, Mulcahy D, Andrews NP, Husain S, Panza JA, Cannon RO.
    Circulation; 1997 Jan 07; 95(1):104-10. PubMed ID: 8994424
    [Abstract] [Full Text] [Related]

  • 38. The insertion/deletion polymorphism of the angiotensin-converting enzyme gene determines coronary vascular tone and nitric oxide activity.
    Prasad A, Narayanan S, Waclawiw MA, Epstein N, Quyyumi AA.
    J Am Coll Cardiol; 2000 Nov 01; 36(5):1579-86. PubMed ID: 11079661
    [Abstract] [Full Text] [Related]

  • 39. Impact of coronary risk factors on contribution of nitric oxide and adenosine to metabolic coronary vasodilation in humans.
    Minamino T, Kitakaze M, Matsumura Y, Nishida K, Kato Y, Hashimura K, Matsu-Ura Y, Funaya H, Sato H, Kuzuya T, Hori M.
    J Am Coll Cardiol; 1998 May 01; 31(6):1274-9. PubMed ID: 9581720
    [Abstract] [Full Text] [Related]

  • 40. Differential effects of nitric oxide synthase inhibitors on endothelium-dependent and nitrergic nerve-mediated vasodilatation in the bovine ciliary artery.
    Overend J, Martin W.
    Br J Pharmacol; 2007 Feb 01; 150(4):488-93. PubMed ID: 17211453
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.